Eyes on New Product Development.Published in:Journal of Ocular Pharmacology & Therapeutics, 2014, v. 30, n. 5, p. 371, doi. 10.1089/jop.2014.1507By:Novack, Gary D.Publication type:Article
Genentech raises stakes on PARP inhibitors.Published in:Nature Biotechnology, 2006, v. 24, n. 10, p. 1179, doi. 10.1038/nbt1006-1179By:Sheridan, CormacPublication type:Article
Phase II clinical trial on new glaucoma drug yields promising results.Published in:Expert Review of Ophthalmology, 2011, v. 6, n. 4, p. 401Publication type:Article